Expression of complement C3b/C4b receptors (CR1) on erythrocytes from patients with myasthenia gravis | Zendy

Vedeler C. A. | Zendy; Gilhus N. E. | Zendy; Matre R. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Expression of complement C3b/C4b receptors (CR1) on erythrocytes from patients with myasthenia gravis

Author(s) -

Vedeler C. A.,

Gilhus N. E.,

Matre R.

Publication year - 1990

Publication title -

acta neurologica scandinavica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.967

H-Index - 95

eISSN - 1600-0404

pISSN - 0001-6314

DOI - 10.1111/j.1600-0404.1990.tb01616.x

Subject(s) - myasthenia gravis , receptor , hemagglutination , immunology , complement system , complement (music) , medicine , acetylcholine receptor , complement receptor , antibody , biology , gene , biochemistry , complementation , phenotype

The complement C3b/C4b receptor (CR1) expression on erythrocytes (E) (ECR1) from patients with myasthenia gravis (MG) and from blood donors was measured using haemadsorption and indirect heamagglutination techniques. The ECR1 expression in patients with MG appeared to be normal. This was also true for the subgroup of MG patients with additional autoimmune diseases. No correlation between ECR1 expression and severity of myasthenic symptoms was demonstrated.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research